Navigation Links
In a Down Economy, Women's Health Company Announces Growth
Date:11/13/2008

WAYNE, Pa., Nov. 13 /PRNewswire/ -- At a time when industry retrenchment, lay-offs and even bail outs dominate the news, a specialty pharmaceutical company located outside Philadelphia is experiencing growth. This week, FemmePharma Global Healthcare, Inc announces the establishment of a new division, FemmePharma Mental Healthcare, Central Nervous System, that will focus on central nervous system (CNS) disorders in women.

"We are energized to expand our commitment in women's health even at a time when the pharmaceutical industry is retreating in this area," says FemmePharma's President and CEO Gerianne Tringali DiPiano. "For FemmePharma, these are times which provide a wealth of opportunities in women's health."

Since its establishment in 1996, FemmePharma has focused on women's gynecological health issues, including urinary incontinence and fibrocystic breast disease. With its expansion into CNS, that focus is growing to develop treatments particularly for depression (including postpartum depression), anxiety disorders, eating disorders and neuropathic pain specific to women.

"We know that women respond differently than men to medications for depression," Tringali DiPiano says, referring to a study published in 2006 in the Journal of Affective Disorders. "And this is just one example. Understanding and developing treatments that respond to women's unique health challenges is FemmePharma's mission so our expansion into CNS disorders in women represents a natural progression," Tringali DiPiano says.

While FemmePharma continues to invest and grow, the pharmaceutical industry in general is withdrawing. In April of this year, a Wall Street Journal website estimated that as many as 25,000 pharmaceutical jobs were expected to be eliminated in 2008. And in October, Wyeth announced that it would eliminate discovery work in women's health while reducing its therapeutic areas from 14 to six.

Tringali DiPiano says this represents a concern for her personally while providing an exciting opportunity for her company.

"The gap in developing treatments unique to women is widening even though there are significant unmet needs," Tringali DiPiano says. "Without question our expansion into CNS is an indication of our continued growth and commitment to women and their unique health needs."

The women's health sector represents an estimated $116 billion market by the year 2010, according to a report by Research and Markets.com.


'/>"/>
SOURCE FemmePharma Global Healthcare, Inc
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Economy, Health Care, and Gas Prices Top Issues for Women Business Owners
2. Ban on betting would boost ailing economy, gambling critic says
3. Despite U.S. economy, more Americans seeking cosmetic surgery overseas
4. Womenshealthchannel Enhancements Support Pregnant Teens
5. Penn study finds pro-death proteins required to regulate healthy immune function
6. UCLA researchers identify markers that may predict diabetes in still-healthy people
7. Air pollution linked to cardiovascular risk indices in healthy young adults
8. More proof needed of safety and quality of electronic personal health records
9. Health care incentive model offers collaborative approach
10. Loneliness is bad for your health
11. Mailman School of Public Health study examines link between racial discrimination and substance use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Qualidigm , the mission-driven national ... a new, more expansive office space in order to accommodate its growing number ... office building in Wethersfield, Conn. located at 936 Silas Deane Highway and immediately ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of corrosive ions found in power plant water and steam. , Chlorides and ... turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions ...
(Date:3/28/2017)... ... 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics ... in the country to sit on the 2017 National Advisory Board for Allergan’s Facial ... Dr. Harper helped propel the clinic from a small start-up to number 78 in ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... ... 28, 2017 , ... With expansion and efficiency in mind, Patten Seed Company ... seed processing plant opened in Marshallville in 2006, and a bagging and shipping facility ... for transition of Patten Seed operations to the Middle Georgia location from their previous ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  A new survey from the ... Competitive Bidding Program (CBP) significantly reduced beneficiary choice and ... of choice forces beneficiaries to switch to unfamiliar or ... AADE,s survey is the latest in ... pointing out the inherent problems with the CBP. Last ...
(Date:3/27/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... an immunotherapy for the treatment of multiple cancers, obtained through ... at the upcoming American Association for Cancer Research (AACR) ... to be held on April 1-5, 2017. ... An abstract titled ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
Breaking Medicine Technology: